For 2027 entry, the first stage of ophthalmology ST1 shortlisting is based exclusively on the MSRA score. The specialty's applicant guide says: "Candidates will be ranked solely on their MSRA score. Candidates self-scoring 19 or less will not progress beyond this point of the selection process regardless of their MSRA score. The highest scoring 350 candidates, will progress to the next stage and their self-assessment scores will be verified."
The guide also says "minimum of 19 points to continue", which conflicts with the stricter wording above. Until the recruitment office issues a correction, the safer reading is that a score of 19 or less will not progress. The official 2026 guide described first-stage shortlisting as a combination of MSRA and unverified self-assessment. For 2027, MSRA rank stands alone. The applicant guide also confirms that the MSRA drops out at the offer stage: the verified Evidence Folder has a maximum 50 points and the Online Assessment has a maximum 50 points.
The Medical Training (Prioritisation) Act also applies from shortlisting through offers for 2027 recruitment. No official source says it caused the ophthalmology change. Our Prioritisation Act guide explains the priority groups and the regulations that were still pending on this page's update date.
Selection moves from MSRA rank to portfolio and assessment scores
Your Oriel application is first checked against the essential eligibility requirements. That includes evidence of foundation competence. Depending on your training history, this may be a recent Foundation Programme certificate or the current Certificate of Readiness to Enter Specialty Training. The CREST form guide covers who needs one, who can sign it and why a single "unable to confirm" answer can stop an application. Progress in the recruitment system can precede the final eligibility checks, so unsatisfactory evidence may still end an application. A mismatch between the person specification and your documents can therefore stop you after apparent progress.
Every applicant must sit the MSRA; non-attendance means withdrawal. For first-stage shortlisting, candidates are ordered solely by that score, subject to the stricter published portfolio wording that 19 or less will not progress. The highest-scoring 350 who clear that condition have their evidence folders reviewed and their claimed scores verified. Verification creates a second ranked list based solely on the verified self-assessment score. A verified score below 20 ends progression, then the highest-ranking 260 candidates are invited to the Online Assessment. A reserve candidate may be called up until three working days before it.
Reaching offers requires at least 40% in the assessment; final ranking then gives 50 points each to the verified Evidence Folder and Online Assessment.
The online interview has two stations. Each lasts up to 10 minutes, with five minutes to read and prepare beforehand. The first is a "medical consultation focusing on clinical knowledge" with an actor playing a patient or carer. Two assessors observe. The second uses the same consultation format but focuses on a "difficult communication or ethical scenario". You may begin with either station.
This is closer to a consultation than a rapid-fire viva. Clinical accuracy matters, and the actor must be able to follow you. The preparation time allows you to identify the central problem and order your response.
The evidence folder supplies half the final score
The folder is built across eight broad domains. The examples below are indicative, drawn from the recent published framework and an IMG-focused derivative account of the scoring. They show the sort of work that has scored well. Exact 2027 claims need to follow the official evidence-folder scoring framework released through the recruitment page.
| Domain | Evidence with stronger scoring potential |
|---|---|
| Qualifications and examinations | Recognised additional qualifications and examinations. A first-attempt FRCOphth Part 1 pass has been a high-value item. |
| Commitment and specialty links | A taster, documented clinic or theatre exposure, and qualifying EyeSi simulation. Recent derivative guidance used blocks of at least four EyeSi hours. |
| Publications | First-author original research indexed on PubMed has scored much better than a case report or a paper with a minor authorship position. |
| Audit and quality improvement | Leading a completed, well-evidenced project and showing reach beyond a local exercise. |
| Presentations | Oral work at national or international meetings has tended to outrank local work and posters. |
| Prizes and awards | National undergraduate prizes and exceptional degree performance, a difficult domain for many doctors who qualified abroad. |
| Teaching and education | A sustained teaching programme with feedback, or a recognised medical-education qualification, is stronger than an isolated session. |
| Professionalism and MSF | Recent multisource feedback with the required range of respondents and documentation. |
One administrative rule is easy to breach: "any one piece of evidence can only be used once and uploaded against only one domain." Each document therefore needs a single home before upload. If one certificate could support teaching or commitment to specialty, it belongs in the domain where it makes the clearest claim. A list of the eight domains, the score you can defend in each and the document that proves it will expose gaps before upload. It will also show which claims rely on a generic attendance certificate.
Applications rose to 21.54 per post in 2025
NHS England recorded 1,383 applications for 96 ophthalmology ST1 posts in 2024, a ratio of 14.41:1. In 2025 it was 2,197 applications for 102 posts, or 21.54:1. These are two of the steepest ratios in the MSRA specialty set, and they describe applications rather than unique doctors. The 2027 applicant guide gives the post figure as up to 90. An ophthalmology-specific breakdown of the 2026 prioritisation result remains unpublished, so NHS England's aggregate fill rate cannot answer what happened within this specialty. The historical table and its limits are set out in our MSRA scores by specialty guide.
Applications close on 19 November 2026
| Stage | Date or status |
|---|---|
| Applications open | 10:00 on Thursday 22 October 2026 |
| Applications close | 16:00 on Thursday 19 November 2026 |
| Interview window | 11 January to 2 April 2027 |
| Documentation upload window | January 2027 |
| Evidence-folder feedback | February 2027 |
| Invitations, preferences, interviews and feedback | March 2027 |
| Offers commence | Towards the end of March 2027 |
| Posts commence | August 2027 onwards |
The published timetable gives months for the specialty stages, so your Oriel invitation supplies the appointment time and final evidence instructions.
Training normally lasts seven years
Ophthalmic Specialist Training is a seven-year run-through programme from ST1 to ST7. Satisfactory progression and the required examinations lead to CCT. Early completion has limited scope and needs educational approval. At the time of writing, seven years is the programme length, but less-than-full-time training or time out can take longer.
Some portfolio points are unavailable after medical school
IMGs face a structural disadvantage in several evidence domains. An IMG account in the Journal of the Foundations of Ophthalmology points out that some scorable achievements belong to medical-school years, including undergraduate prizes and the Duke Elder examination.
A doctor who discovers UK ophthalmology after graduation has already missed that window.
The same account describes ophthalmology SHO posts as scarce, which restricts access to cases, clinics and EyeSi time. Portfolio building is expensive. Recognition of home-country qualifications can also be unclear. Although evidence can still be developed, your existing evidence and priority status should inform an assessment of whether further spending has a credible route to selection, alongside the scarcity of posts, restricted access, cost and unclear recognition of home-country qualifications.
A high MSRA score is still necessary for the top-350 cut. A portfolio above the minimum remains necessary for verification and later ranking. Priority status may decide whether a non-priority applicant reaches a later stage; ophthalmology-specific 2026 data remain unavailable.
If ST1 is unworkable this cycle, the IMG options guide sets out service posts and other routes, with the training outcome of each.
The Dual Sponsorship Scheme sits outside ST1
The RCOphth Dual Sponsorship Scheme is a targeted, time-limited UK attachment for an international ophthalmologist, outside ST1 and CCT training. It carries no National Training Number. The initial period is 12 months. An extension of three to 12 months may be approved in exceptional circumstances, and the doctor must agree to return to their country of origin afterwards.
The practice requirement says you must have been "engaged in medical practice for three out of the last five years" and show "at least 10 months of medical practice within the most recent 12 months". Internships, observerships and clinical attachments are excluded from that practice requirement.
English evidence must be IELTS Academic at 7.0 in every component and 7.5 overall, or OET Medicine grade B in every area in the same, most recent sitting. You must identify your own UK and overseas sponsors and a suitable post. The College approves the post after you have found it. The UK sponsor must be an RCOphth Fellow, Member or Affiliate Member holding an NHS consultant post. DSS suits a defined training need when the sponsors, post and return plan already exist, and remains separate from run-through training.
Practise the MSRA questions that determine ophthalmology's first-stage ranking: try ProMSRA free / see pricing.
Questions ophthalmology applicants ask
What MSRA score do you need for ophthalmology 2027?
No defensible number has been published. The top 350 progress by relative MSRA rank after applying the portfolio floor, and the highest 260 on verified self-assessment then reach the Online Assessment. The guide's stricter wording is: "19 or less will not progress".
Does your portfolio still matter?
Yes. It sets a floor, decides the second ranking after verification and contributes 50% of the confirmed 2027 offer score; the Online Assessment contributes the other 50%.
Can IMGs get ophthalmology ST1?
IMGs can apply if they meet the person specification, but the obstacles are substantial: early-career portfolio points, restricted access to ophthalmology experience, cost, a 21.54:1 recent ratio and prioritisation from shortlisting onwards. Specialty-specific 2026 data cannot promise a later-stage place because NHS England has not published that breakdown.
What is the RCOphth Dual Sponsorship Scheme?
It is a 12-month targeted ophthalmology attachment for eligible international doctors, sometimes extended by three to 12 months. You arrange the post and both sponsors, and agree to return home afterwards; the scheme sits outside National Training Number and CCT training.